Hollister Incorporated Advances the Future of Ostomy and Incontinence Care with People-Centered Innovation

Recently announced 2022 U.S. contract wins reinforce focus on quality of life and dignity

Libertyville, Illinois., June 16, 2022 /PRNewswire/—— Hollister Incorporated, a global medical products company, recently announced a New contract for Hollister ostomy care productstogether with a Renew Used in the company’s incontinence care product portfolio.These Important Announcements Bring Trusted Hollister Medical Products to AMA Member Hospitals and Health Systems U.S.underscoring the company’s strong commitment to high-quality care and innovation, focusing on ostomy patients and those using intermittent catheters.

“People with intermittent catheters typically use multiple catheters per day, and people with ostomy use ostomy products 24/7,” says Kathy HanHollister General Manager, U.S.“Providing high-quality medical products for these very personal situations is our way of demonstrating our commitment to human dignity and person-centred care, and every contract we sign is an opportunity to further that commitment. We look forward to Join our GPO partners and other healthcare organizations to help those who use our products and services have a more rewarding life.”

At Hollister Incorporated, people using ostomy and incontinence care products are at the forefront of everything the company does. Listening to and responding to people’s needs is what drives the company’s research and development, which focuses on products and solutions that empower dignity and enhance the quality of life.

In stoma care, maintaining the health of the skin around the stoma is critical for comfort and quality of life; maintaining healthy skin may also reduce a person’s follow-up care, which may involve additional medical costs. Hollister pioneered peri-stoma skin health, with a study confirming that CeraPlus™ Skin Barrier* is more effective at protecting the skin from multiple barrier changes than other products.1 Research has shown that participants using Hollister CeraPlus Skin Barrier are less likely to experience skin problems around the stoma. In addition, another study showed that if there is a skin problem, the use of CeraPlus Skin Barrier can help solve the skin problem (53% of those who used CeraPlus Skin Barrier, 29% of those who did not). 2 The CeraPlus™ portfolio is if only America’s advanced line of ostomy products infused with ceramides to protect skin from day one.3

In incontinence care and urology, Hollister product innovation focuses on minimizing the risk of infection while enabling people to live meaningful and dignified lives.The company’s VaPro™ Intermittent Catheter offers 100% “non-contact protection” with an innovative protective tip and sleeve4 It has been shown in independent studies to reduce the transmission of uropathogens that can cause urinary tract infections (UTIs).4

Another incontinence care product designed for women is the new Infyna Chic™ Intermittent Catheter. This advanced conduit offers a unique and innovative combination of modern design, color, performance and discretion.5

Hollister combines its drive for people-centered innovation with long-term support for Bold Girls, United Spine Association, and United Stomach Society of America, where the community can peer-to-peer discussions about advocacy strategies and mental health resources. Hollister also partners with leading adaptive athletics programs University of Alabama and San Diego State University.

“Last year we celebrated 100th The anniversary of our parent company, John Dickinson Schneider Inc.,” said Haan. “We are changing the lives of people in every corner of the world today, but what inspires and motivates us is the future — a future that Hollister Incorporated will continue to prioritize. Human dignity and drive product innovation. “

About Hollister Corporation

Hollister Incorporated is an independent employee-owned company that develops, manufactures and markets healthcare products worldwide. The company develops and manufactures products for ostomy care, incontinence care and critical care, as well as educational support materials for patients and healthcare professionals.The company’s global headquarters is located in Libertyville, Illinoisforty miles north of downtown chicago, Hollister has manufacturing and distribution facilities on three continents and markets and sells its products in nearly 80 countries around the world. As a wholly owned subsidiary of John Dickinson Schneider Inc. (JDS Inc.), Hollister follows JDS Inc.’s shared mission of making the lives of those who use the company’s products and services more valuable and dignified.

Media Liaison
Jennifer McGrath
corporate communications
[email protected]

Related Links

refer to

  1. Grove G., Houser T, Sibbald G, Salvadalena G. Measuring the epidermal effect of the ostomy skin barrier. Skin Reservoir Technique. 2019;25:179-186 https://doi.org/10.1111/srt.12630
  2. Colwell et al, (2018) Randomised controlled trial to determine differences in stoma skin condition and economic impact (ADVOCATE), Journal of Wound, Stoma and Incontinence Care, 45(1), 37-42
  3. Archived Data, CL-000545, 2021
  4. Archived Data, TR-00453, 2021
  5. Archived data, Ref-01714, 2019

*CeraPlus products contain Remois technology from Alcare Co., LTD

Always read the Instructions for Use for information on Contraindications, Warnings, Precautions and Instructions for intended use before use.

Hollister, the Hollister logo, CeraPlus, Infyna Chic and VaPro are trademarks of Hollister Incorporated. @2022 Hollister Company

Source Hollister Incorporated


Leave a Reply

Your email address will not be published. Required fields are marked *